Khiron Life Sciences to Present at Upcoming October Investor Conferences

Published: Oct. 1, 2021 at 3:40 PM MDT|Updated: Oct. 4, 2021 at 2:00 PM MDT

TORONTO, Oct. 4, 2021 /PRNewswire/ – Khiron Life Sciences Corp. (“Khiron” or the “Company”) (TSXV: KHRN) (OTCQX: KHRNF) (Frankfurt: A2JMZC), a vertically integrated cannabis leader with core operations in Latin America and Europe, is scheduled to participate in the following virtual investor conferences in October 2021:

Khiron Life Sciences Corp. Logo (CNW Group/Khiron Life Sciences Corp.)

Attending 1×1 Meetings: Tuesday, October 5th 2021
Moderator: Aaron Grey, Managing Director, Equity Research Consumer & Cannabis

Khiron Presentation: Thursday, October 7th at 9:30 p.m. ET

Panel “Growing without Borders, an International Perspective”:
Thursday, October 7th at 11:30 p.m. ET

Thursday, October 15th at 4:00 p.m ET
Panel Participation: The Latin American Cannabis Supply Chain: Do’s, Don’ts and Industry Domination

Marriott Marquis Hotel in New York City

  • Khiron Presentation: Friday, October 15th at 3:45 p.m ET
  • Virtual executive interview with Mr. Vicente Fox: Thursday, October 14th & 15th at 1:10 p.m ET
  • Panel: International Spotlight – Continued Cannabis Expansion in European Markets: Friday, October 15th at 2:10 p.m ET

A.G.P’s hosted events are intended for prospective and existing A.G.P’s clients only. To listen to the live event, please contact you’re A.G.P’s representative with interest.

For more information about the Lytham Partners Conference or to schedule a 1-on-1 meeting with Khiron, please contact a Lytham Partners representative at 1×[email protected]  or register at

Interested parties for the Benzinga Cannabis Capital Conference can register to attend here.

Members of the Khiron management will also be holding one-on-one investor meetings throughout the day. For more information about the conference or to schedule a 1-on-1 meeting with Khiron management, please call the company’s investor relations team at 1-647-556-5750

Interested parties for the MJBizCon can register to attend here.

About Khiron Life Sciences Corp.
Khiron is a leading vertically integrated international medical cannabis company with core operations in Latin America and Europe. Leveraging wholly-owned medical health clinics and proprietary telemedicine platforms, Khiron combines a patient-oriented approach, physician education programs, scientific expertise, product innovation, and agricultural infrastructure to drive prescriptions and brand loyalty with patients worldwide. The Company has a sales presence in Colombia, Peru, Germany, UK, and Brazil and is positioned to commence sales in Mexico. The Company is led by Co-founder and Chief Executive Officer, Alvaro Torres, together with an experienced and diverse executive team and Board of Directors.

Visit Khiron online at

Cautionary Notes

Forward-Looking Statements

This press release may contain certain “forward-looking information” and “forward-looking statements” within the meaning of applicable securities legislation. All information contained herein that is not historical in nature may constitute forward-looking information. Khiron undertakes no obligation to comment on analyses, expectations or statements made by third-parties in respect of Khiron, its securities, or financial or operating results (as applicable). Although Khiron believes that the expectations reflected in forward-looking statements in this press release are reasonable, such forward-looking statement has been based on expectations, factors and assumptions concerning future events which may prove to be inaccurate and are subject to numerous risks and uncertainties, certain of which are beyond Khiron’s control, including the risk factors discussed in Khiron’s Annual Information Form which is available on Khiron’s SEDAR profile at The forward-looking information contained in this press release is expressly qualified by this cautionary statement and is made as of the date hereof. Khiron disclaims any intention and has no obligation or responsibility, except as required by law, to update or revise any forward-looking information, whether as a result of new information, future events or otherwise.

Neither the TSXV nor its Regulation Services Provider (as that term is defined in the policies of the TSXV) accepts responsibility for the adequacy or accuracy of this press release.

View original content to download multimedia:

SOURCE Khiron Life Sciences Corp.

The above press release was provided courtesy of PRNewswire. The views, opinions and statements in the press release are not endorsed by Gray Media Group nor do they necessarily state or reflect those of Gray Media Group, Inc.